DLPIC
IRWD icon

Davide Leone & Partners Investment Company’s Ironwood Pharmaceuticals IRWD Stock Holding History

Davide Leone & Partners Investment Company’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-87,677
Closed -$980K – 90
2021
Q1 		$980K Buy
+87,677
New +$926K 0.12% 85

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Davide Leone & Partners Investment Company's IRWD Position: Q2 2021 in Review

Davide Leone & Partners Investment Company sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2021, closing a stake of 87,677 shares — an estimated $980K sold.

Davide Leone & Partners Investment Company first reported a position in IRWD in Q1 2021 and held it in 1 quarter. The position peaked at $980K in Q1 2021. 209 funds tracked by Wall St. Rank hold IRWD as of Q2 2021.

  • Davide Leone & Partners Investment Company reported no remaining Ironwood Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Davide Leone & Partners Investment Company sold 87,677 Ironwood Pharmaceuticals shares in Q2 2021, an estimated $980K.
  • Davide Leone & Partners Investment Company first reported a position in Ironwood Pharmaceuticals in Q1 2021 and held it in 1 quarter.
  • Davide Leone & Partners Investment Company's Ironwood Pharmaceuticals position peaked at $980K in Q1 2021.
  • 209 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2021.

Based on Davide Leone & Partners Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.